Codexis, Inc.

NasdaqGS:CDXS

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Chemicals & Advanced Materials

💊 Pharmaceuticals

Location

United States

Market Cap

USD 231.14 M

Share Price

USD 2.79

Avg Daily Volume

890,546

Change (1 day)

-1.06%

Change (1 year)

-23.14%

Change (YTD)

-41.51%

Codexis, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2025: -135.81%

Codexis, Inc. EBIT Margin is -135.81% for the Trailing 12 Months (TTM) ending March 31, 2025, a 133.44% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.

Codexis, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was -58.18%, a 40.48% change year over year.
Codexis, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was -41.41%, a 133.75% change year over year.
Codexis, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was -17.72%, a -49.16% change year over year.
Codexis, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was -34.85%, a 55.50% change year over year.